Blood Biomarkers for Stroke Diagnosis and Management

Adams, H. P. Jr., Bendixen, B. H., Kappelle, L. J., Biller, J., Love, B. B., Gordon, D. L., et al. (1993). Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke, 24(1), 35–41.CrossRefPubMed

Albers, G. W., Marks, M. P., Kemp, S., Christensen, S., Tsai, J. P., Ortega-Gutierrez, S., et al. (2018). Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. The New England Journal of Medicine, 378(8), 708–718. https://doi.org/10.1056/NEJMoa1713973.CrossRefPubMedPubMedCentral

Allard, L., Burkhard, P. R., Lescuyer, P., Burgess, J. A., Walter, N., Hochstrasser, D. F., et al. (2005). PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. Clinical Chemistry, 51(11), 2043–2051. https://doi.org/10.1373/clinchem.2005.053942.CrossRefPubMed

Alvarez-Perez, F. J., Castelo-Branco, M., & Alvarez-Sabin, J. (2011). Usefulness of measurement of fibrinogen, D-dimer, D-dimer/fibrinogen ratio, C reactive protein and erythrocyte sedimentation rate to assess the pathophysiology and mechanism of ischaemic stroke. Journal of Neurology, Neurosurgery, and Psychiatry, 82(9), 986–992. https://doi.org/10.1136/jnnp.2010.230870.CrossRefPubMed

Anand, N., & Stead, L. G. (2005). Neuron-specific enolase as a marker for acute ischemic stroke: A systematic review. Cerebrovascular Diseases, 20(4), 213–219. https://doi.org/10.1159/000087701.CrossRefPubMed

Anderson, C. S., Selim, M. H., Molina, C. A., & Qureshi, A. I. (2017). Intensive blood pressure lowering in intracerebral hemorrhage. Stroke, 48(7), 2034–2037. https://doi.org/10.1161/STROKEAHA.117.016185.CrossRefPubMedPubMedCentral

Arenillas, J. F., Alvarez-Sabin, J., Molina, C. A., Chacon, P., Fernandez-Cadenas, I., Ribo, M., et al. (2008). Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinflammatory state and impaired fibrinolysis. Stroke, 39(5), 1456–1463. https://doi.org/10.1161/STROKEAHA.107.498600.CrossRefPubMed

Ariesen, M. J., Claus, S. P., Rinkel, G. J., & Algra, A. (2003). Risk factors for intracerebral hemorrhage in the general population: A systematic review. Stroke, 34(8), 2060–2065. https://doi.org/10.1161/01.STR.0000080678.09344.8D.CrossRefPubMed

Atkinson, A. J., Colburn, W. A., DeGruttola, A. G., DeMets, D. L., Downing, G. J., Hoth, J. F., et al. (2001). Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clinical Pharmacology & Therapeutics, 69(3), 89–95. https://doi.org/10.1067/mcp.2001.113989.CrossRef

Bai, J., Sun, H., Xie, L., Zhu, Y., & Feng, Y. (2018). Detection of cardioembolic stroke with B-type natriuretic peptide or N-terminal pro-BNP: A comparative diagnostic meta-analysis. International Journal of Neuroscience. https://doi.org/10.1080/00207454.2017.1408612.CrossRefPubMed

Balami, J. S., Chen, R. L., Grunwald, I. Q., & Buchan, A. M. (2011). Neurological complications of acute ischaemic stroke. The Lancet Neurology, 10(4), 357–371. https://doi.org/10.1016/S1474-4422(10)70313-6.CrossRefPubMed

Balami, J. S., Hadley, G., Sutherland, B. A., Karbalai, H., & Buchan, A. M. (2013). The exact science of stroke thrombolysis and the quiet art of patient selection. Brain, 136(Pt 12), 3528–3553. https://doi.org/10.1093/brain/awt201.CrossRefPubMed

Bang, O. Y. (2017). Advances in biomarker for stroke patients: From marker to regulator. Precision and Future Medicine, 1(1), 32–42. https://doi.org/10.23838/pfm.2017.00052.CrossRef

Bang, O. Y., Saver, J. L., Ovbiagele, B., Choi, Y. J., Yoon, S. R., & Lee, K. H. (2007). Adiponectin levels in patients with intracranial atherosclerosis. Neurology, 68(22), 1931–1937. https://doi.org/10.1212/01.wnl.0000263186.20988.9f.CrossRefPubMed

Bhatia, R., Hill, M. D., Shobha, N., Menon, B., Bal, S., Kochar, P., et al. (2010). Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: Real-world experience and a call for action. Stroke, 41(10), 2254–2258. https://doi.org/10.1161/STROKEAHA.110.592535.CrossRefPubMed

Bitsch, A., Klene, W., Murtada, L., Prange, H., & Rieckmann, P. (1998). A longitudinal prospective study of soluble adhesion molecules in acute stroke. Stroke, 29(10), 2129–2135.CrossRefPubMed

Bozkurt, S., Kaya, E. B., Okutucu, S., Aytemir, K., Coskun, F., & Oto, A. (2011). The diagnostic and prognostic value of first hour glycogen phosphorylase isoenzyme BB level in acute coronary syndrome. Cardiology Journal, 18(5), 496–502.CrossRefPubMed

Briard, J. N., Zewude, R. T., Kate, M. P., Rowe, B. H., Buck, B., Butcher, K., et al. (2018). Stroke mimics transported by emergency medical services to a comprehensive stroke center: The magnitude of the problem. Journal of Stroke and Cerebrovascular Diseases, 27(10), 2738–2745. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.05.046.CrossRef

Brott, T. G., Lyden, P., Grotta, J. C., Kwiatkowski, T. G., Levine, S. R., Frankel, M. R., et al. (1997). Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. Stroke, 28(11), 2109–2118.CrossRef

Brunkhorst, R., Pfeilschifter, W., & Foerch, C. (2010). Astroglial proteins as diagnostic markers of acute intracerebral hemorrhage-pathophysiological background and clinical findings. Translational Stroke Research, 1(4), 246–251. https://doi.org/10.1007/s12975-010-0040-6.CrossRefPubMed

Bruns, A. H., Oosterheert, J. J., Hak, E., & Hoepelman, A. I. (2008). Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. European Respiratory Journal, 32(3), 726–732. https://doi.org/10.1183/09031936.00003608.CrossRefPubMed

Bustamante, A., Lopez-Cancio, E., Pich, S., Penalba, A., Giralt, D., Garcia-Berrocoso, T., et al. (2017a). Blood biomarkers for the early diagnosis of stroke: The stroke-chip study. Stroke, 48(9), 2419–2425. https://doi.org/10.1161/STROKEAHA.117.017076.CrossRefPubMed

Bustamante, A., Ning, M., Garcia-Berrocoso, T., Penalba, A., Boada, C., Simats, A., et al. (2018). Usefulness of ADAMTS13 to predict response to recanalization therapies in acute ischemic stroke. Neurology, 90(12), e995–e1004. https://doi.org/10.1212/WNL.0000000000005162.CrossRefPubMedPubMedCentral

Bustamante, A., Vilar-Bergua, A., Guettier, S., Sanchez-Poblet, J., Garcia-Berrocoso, T., Giralt, D., et al. (2017b). C-reactive protein in the detection of post-stroke infections: Systematic review and individual participant data analysis. Journal of Neurochemistry, 141(2), 305–314. https://doi.org/10.1111/jnc.13973.CrossRefPubMed

Cabral, N. L., Muller, M., Franco, S. C., Longo, A., Moro, C., Nagel, V., et al. (2015). Three-year survival and recurrence after first-ever stroke: The Joinville stroke registry. BMC Neurology, 15, 70. https://doi.org/10.1186/s12883-015-0317-1.CrossRefPubMedPubMedCentral

Campbell, B. C. V., Mitchell, P. J., Churilov, L., Yassi, N., Kleinig, T. J., Dowling, R. J., et al. (2018). Tenecteplase versus alteplase before thrombectomy for ischemic stroke. The New England Journal of Medicine, 378(17), 1573–1582. https://doi.org/10.1056/NEJMoa1716405.CrossRefPubMed

Carbone, F., Burger, F., Roversi, G., Tamborino, C., Casetta, I., Seraceni, S., et al. (2015). Leptin/adiponectin ratio predicts poststroke neurological outcome. European Journal of Clinical Investigation, 45(11), 1184–1191. https://doi.org/10.1111/eci.12538.CrossRefPubMed

Castellanos, M., Castillo, J., Garcia, M. M., Leira, R., Serena, J., Chamorro, A., et al. (2002). Inflammation-mediated damage in progressing lacunar infarctions: A potential therapeutic target. Stroke, 33(4), 982–987.CrossRefPubMed

Castellanos, M., Leira, R., Serena, J., Blanco, M., Pedraza, S., Castillo, J., et al. (2004). Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke. Stroke, 35(7), 1671–1676. https://doi.org/10.1161/01.STR.0000131656.47979.39.CrossRefPubMed

Castellanos, M., Leira, R., Serena, J., Pumar, J. M., Lizasoain, I., Castillo, J., et al. (2003). Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke, 34(1), 40–46.CrossRefPubMed

Castellanos, M., Sobrino, T., & Castillo, J. (2006). Evolving paradigms for neuroprotection: Molecular identification of ischemic penumbra. Cerebrovascular Diseases, 21(Suppl 2), 71–79. https://doi.org/10.1159/000091706.CrossRefPubMed

Castellanos, M., Sobrino, T., Millan, M., Garcia, M., Arenillas, J., Nombela, F., et al. (2007). Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: A multicenter confirmatory study. Stroke, 38(6), 1855–1859. https://doi.org/10.1161/STROKEAHA.106.481556.CrossRefPubMed

Castellanos, M., Sobrino, T., Pedraza, S., Moldes, O., Pumar, J. M., Silva, Y., et al. (2008). High plasma glutamate concentrations are associated with infarct growth in acute ischemic stroke. Neurology, 71(23), 1862–1868. https://doi.org/10.1212/01.wnl.0000326064.42186.7e.CrossRefPubMed

Castillo, J., Rama, R., & Davalos, A. (2000). Nitric oxide-related brain damage in acute ischemic stroke. Stroke, 31(4), 852–857.CrossRefPubMed

Chaturvedi, S., & Bhattacharya, P. (2014). Large artery atherosclerosis: Carotid stenosis, vertebral artery disease, and intracranial atherosclerosis. Continuum (Minneap Minn), 20(2 Cerebrovascular Disease), 323–334. https://doi.org/10.1212/01.CON.0000446104.90043.a5.CrossRef

Chen, X. L., Li, Q., Huang, W. S., Lin, Y. S., Xue, J., Wang, B., et al. (2017). Serum YKL-40, a prognostic marker in patients with large-artery atherosclerotic stroke. Acta Neurologica Scandinavica, 136(2), 97–102. https://doi.org/10.1111/ane.12688.CrossRefPubMed

Choi, J. Y., Kim, J. S., Kim, J. H., Oh, K., Koh, S. B., & Seo, W. K. (2014). High free fatty acid level is associated with recurrent stroke in cardioembolic stroke patients. Neurology, 82(13), 1142–1148. https://doi.org/10.1212/WNL.0000000000000264.CrossRefPubMed

Crawford, F., Andras, A., Welch, K., Sheares, K., Keeling, D., & Chappell, F. M. (2016). D-dimer test for excluding the diagnosis of pulmonary embolism. Cochrane Library: Cochrane Review, 8, CD010864. https://doi.org/10.1002/14651858.CD010864.pub2.CrossRef

Dambinova, S. A., Khounteev, G. A., Izykenova, G. A., Zavolokov, I. G., Ilyukhina, A. Y., & Skoromets, A. A. (2003). Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clinical Chemistry, 49(10), 1752–1762.CrossRefPubMed

Dasenbrock, H. H., Robertson, F. C., Vaitkevicius, H., Aziz-Sultan, M. A., Guttieres, D., Dunn, I. F., et al. (2017). Timing of decompressive hemicraniectomy for stroke: A nationwide inpatient sample analysis. Stroke, 48(3), 704–711. https://doi.org/10.1161/STROKEAHA.116.014727.CrossRefPubMed

Dastur, C. K., & Yu, W. (2017). Current management of spontaneous intracerebral haemorrhage. Stroke and Vascular Neurology, 2(1), 21–29. https://doi.org/10.1136/svn-2016-000047.CrossRefPubMedPubMedCentral

Davalos, A., Castillo, J., Marrugat, J., Fernandez-Real, J. M., Armengou, A., Cacabelos, P., et al. (2000). Body iron stores and early neurologic deterioration in acute cerebral infarction. Neurology, 54(8), 1568–1574.CrossRefPubMed

De Marchis, G. M., Katan, M., Weck, A., Fluri, F., Foerch, C., Findling, O., et al. (2013). Copeptin adds prognostic information after ischemic stroke: Results from the CoRisk study. Neurology, 80(14), 1278–1286. https://doi.org/10.1212/WNL.0b013e3182887944.CrossRefPubMed

De Marchis, G. M., Weck, A., Audebert, H., Benik, S., Foerch, C., Buhl, D., et al. (2014). Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: Results from the CoRisk study. Stroke, 45(10), 2918–2923. https://doi.org/10.1161/STROKEAHA.114.005584.CrossRefPubMed

de Oliveira Manoel, A. L., Goffi, A., Zampieri, F. G., Turkel-Parrella, D., Duggal, A., Marotta, T. R., et al. (2016). The critical care management of spontaneous intracranial hemorrhage: A contemporary review. Critical Care, 20, 272. https://doi.org/10.1186/s13054-016-1432-0.CrossRefPubMedPubMedCentral

DeGraba, T. J., Siren, A. L., Penix, L., McCarron, R. M., Hargraves, R., Sood, S., et al. (1998). Increased endothelial expression of intercellular adhesion molecule-1 in symptomatic versus asymptomatic human carotid atherosclerotic plaque. Stroke, 29(7), 1405–1410.CrossRefPubMed

del Zoppo, G. J., Levy, D. E., Wasiewski, W. W., Pancioli, A. M., Demchuk, A. M., Trammel, J., et al. (2009). Hyperfibrinogenemia and functional outcome from acute ischemic stroke. Stroke, 40(5), 1687–1691. https://doi.org/10.1161/STROKEAHA.108.527804.CrossRefPubMedPubMedCentral

Delgado, P., Chacon, P., Penalba, A., Pelegri, D., Garcia-Berrocoso, T., Giralt, D., et al. (2012). Lipoprotein-associated phospholipase A(2) activity is associated with large-artery atherosclerotic etiology and recurrent stroke in TIA patients. Cerebrovascular Diseases, 33(2), 150–158. https://doi.org/10.1159/000334193.CrossRefPubMed

Denorme, F., Langhauser, F., Desender, L., Vandenbulcke, A., Rottensteiner, H., Plaimauer, B., et al. (2016). ADAMTS13-mediated thrombolysis of t-PA-resistant occlusions in ischemic stroke in mice. Blood, 127(19), 2337–2345. https://doi.org/10.1182/blood-2015-08-662650.CrossRefPubMed

Dieplinger, B., Bocksrucker, C., Egger, M., Eggers, C., Haltmayer, M., & Mueller, T. (2017). Prognostic value of inflammatory and cardiovascular biomarkers for prediction of 90-day all-cause mortality after acute ischemic stroke-results from the linz stroke unit study. Clinical Chemistry, 63(6), 1101–1109. https://doi.org/10.1373/clinchem.2016.269969.CrossRefPubMed

Dolz, S., Gorriz, D., Tembl, J. I., Sanchez, D., Fortea, G., Parkhutik, V., et al. (2017). Circulating MicroRNAs as novel biomarkers of stenosis progression in asymptomatic carotid stenosis. Stroke, 48(1), 10–16. https://doi.org/10.1161/STROKEAHA.116.013650.CrossRefPubMed

Dykstra-Aiello, C., Jickling, G. C., Ander, B. P., Shroff, N., Zhan, X., Liu, D., et al. (2016). Altered expression of long noncoding RNAs in blood after ischemic stroke and proximity to putative stroke risk loci. Stroke, 47(12), 2896–2903. https://doi.org/10.1161/STROKEAHA.116.013869.CrossRefPubMedPubMedCentral

Efstathiou, S. P., Tsioulos, D. I., Tsiakou, A. G., Gratsias, Y. E., Pefanis, A. V., & Mountokalakis, T. D. (2005). Plasma adiponectin levels and five-year survival after first-ever ischemic stroke. Stroke, 36(9), 1915–1919. https://doi.org/10.1161/01.STR.0000177874.29849.f0.CrossRefPubMed

El Husseini, N., & Laskowitz, D. T. (2010). Clinical application of blood biomarkers in cerebrovascular disease. Expert Review of Neurotherapeutics, 10(2), 189–203. https://doi.org/10.1586/ern.09.151.CrossRefPubMed

Elkind, M. S., Luna, J. M., McClure, L. A., Zhang, Y., Coffey, C. S., Roldan, A., et al. (2014). C-reactive protein as a prognostic marker after lacunar stroke: Levels of inflammatory markers in the treatment of stroke study. Stroke, 45(3), 707–716. https://doi.org/10.1161/STROKEAHA.113.004562.CrossRefPubMedPubMedCentral

Elkind, M. S., Tai, W., Coates, K., Paik, M. C., & Sacco, R. L. (2009). Lipoprotein-associated phospholipase A2 activity and risk of recurrent stroke. Cerebrovascular Diseases, 27(1), 42–50. https://doi.org/10.1159/000172633.CrossRefPubMed

Eng, L. F., Ghirnikar, R. S., & Lee, Y. L. (2000). Glial fibrillary acidic protein: GFAP-thirty-one years (1969–2000). Neurochemical Research, 25(9–10), 1439–1451.CrossRefPubMed

Feinberg, M. W., & Moore, K. J. (2016). MicroRNA regulation of atherosclerosis. Circulation Research, 118(4), 703–720. https://doi.org/10.1161/CIRCRESAHA.115.306300.CrossRefPubMedPubMedCentral

Foerch, C., Montaner, J., Furie, K. L., Ning, M. M., & Lo, E. H. (2009). Invited article: Searching for oracles? Blood biomarkers in acute stroke. Neurology, 73(5), 393–399. https://doi.org/10.1212/WNL.0b013e3181b05ef9.CrossRefPubMedPubMedCentral

Foerch, C., Niessner, M., Back, T., Bauerle, M., De Marchis, G. M., Ferbert, A., et al. (2012). Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke. Clinical Chemistry, 58(1), 237–245. https://doi.org/10.1373/clinchem.2011.172676.CrossRefPubMed

Foerch, C., Otto, B., Singer, O. C., Neumann-Haefelin, T., Yan, B., Berkefeld, J., et al. (2004). Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion. Stroke, 35(9), 2160–2164. https://doi.org/10.1161/01.STR.0000138730.03264.ac.CrossRefPubMed

Foerch, C., Wunderlich, M. T., Dvorak, F., Humpich, M., Kahles, T., Goertler, M., et al. (2007). Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke. Stroke, 38(9), 2491–2495. https://doi.org/10.1161/STROKEAHA.106.480111.CrossRefPubMed

Ganz, P., Amarenco, P., Goldstein, L. B., Sillesen, H., Bao, W., Preston, G. M., et al. (2017). Association of osteopontin, neopterin, and myeloperoxidase with stroke risk in patients with prior stroke or transient ischemic attacks: Results of an analysis of 13 biomarkers from the stroke prevention by aggressive reduction in cholesterol levels trial. Stroke, 48(12), 3223–3231. https://doi.org/10.1161/STROKEAHA.117.017965.CrossRefPubMed

George, P. M., Mlynash, M., Adams, C. M., Kuo, C. J., Albers, G. W., & Olivot, J. M. (2015). Novel TIA biomarkers identified by mass spectrometry-based proteomics. International Journal of Stroke, 10(8), 1204–1211. https://doi.org/10.1111/ijs.12603.CrossRefPubMed

Giles, M. F., & Rothwell, P. M. (2007). Risk of stroke early after transient ischaemic attack: A systematic review and meta-analysis. The Lancet Neurology, 6(12), 1063–1072. https://doi.org/10.1016/S1474-4422(07)70274-0.CrossRefPubMed

Glushakova, O. Y., Glushakov, A. V., Miller, E. R., Valadka, A. B., & Hayes, R. L. (2016). Biomarkers for acute diagnosis and management of stroke in neurointensive care units. Brain Circulation, 2(1), 28–47. https://doi.org/10.4103/2394-8108.178546.CrossRefPubMedPubMedCentral

Haapaniemi, E., & Tatlisumak, T. (2009). Is D-dimer helpful in evaluating stroke patients? A systematic review. Acta Neurol Scand, 119(3), 141–150. https://doi.org/10.1111/j.1600-0404.2008.01081.x.CrossRefPubMed

Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Davalos, A., Guidetti, D., et al. (2008). Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. The New England Journal of Medicine, 359(13), 1317–1329. https://doi.org/10.1056/NEJMoa0804656.CrossRefPubMed

Hart, R. G., Diener, H. C., Coutts, S. B., Easton, J. D., Granger, C. B., O’Donnell, M. J., et al. (2014). Embolic strokes of undetermined source: The case for a new clinical construct. The Lancet Neurology, 13(4), 429–438. https://doi.org/10.1016/S1474-4422(13)70310-7.CrossRefPubMed

Hart, R. G., Sharma, M., Mundl, H., Kasner, S. E., Bangdiwala, S. I., Berkowitz, S. D., et al. (2018). Rivaroxaban for stroke prevention after embolic stroke of undetermined source. The New England Journal of Medicine, 378(23), 2191–2201. https://doi.org/10.1056/NEJMoa1802686.CrossRefPubMed

Hassan, A., Hunt, B. J., O’Sullivan, M., Parmar, K., Bamford, J. M., Briley, D., et al. (2003). Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain, 126(Pt 2), 424–432.CrossRefPubMed

Hu, L., Dong, M. X., Zhao, H., Xu, G. H., & Qin, X. Y. (2016). Fibulin-5: A novel biomarker for evaluating severity and predicting prognosis in patients with acute intracerebral haemorrhage. European Journal of Neurology, 23(7), 1195–1201. https://doi.org/10.1111/ene.13013.CrossRefPubMed

Huang, Y. Q., Li, J., Huang, C., & Feng, Y. Q. (2018). Plasma MicroRNA-29c levels are associated with carotid intima-media thickness and is a potential biomarker for the early detection of atherosclerosis. Cellular Physiology and Biochemistry, 50(2), 452–459. https://doi.org/10.1159/000494158.CrossRefPubMed

Im, H. I., & Kenny, P. J. (2012). MicroRNAs in neuronal function and dysfunction. Trends in Neurosciences, 35(5), 325–334. https://doi.org/10.1016/j.tins.2012.01.004.CrossRefPubMedPubMedCentral

Jaillard, A., Cornu, C., Durieux, A., Moulin, T., Boutitie, F., Lees, K. R., et al. (1999). Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E group. Stroke, 30(7), 1326–1332.CrossRefPubMed

Jauch, E. C., Lindsell, C., Broderick, J., Fagan, S. C., Tilley, B. C., Levine, S. R., et al. (2006). Association of serial biochemical markers with acute ischemic stroke: The National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke, 37(10), 2508–2513. https://doi.org/10.1161/01.STR.0000242290.01174.9e.CrossRefPubMed

Jickling, G. C., Ander, B. P., Shroff, N., Orantia, M., Stamova, B., Dykstra-Aiello, C., et al. (2016). Leukocyte response is regulated by microRNA let7i in patients with acute ischemic stroke. Neurology, 87(21), 2198–2205. https://doi.org/10.1212/WNL.0000000000003354.CrossRefPubMedPubMedCentral

Jickling, G. C., Ander, B. P., Stamova, B., Zhan, X., Liu, D., Rothstein, L., et al. (2013). RNA in blood is altered prior to hemorrhagic transformation in ischemic stroke. Annals of Neurology, 74(2), 232–240. https://doi.org/10.1002/ana.23883.CrossRefPubMedPubMedCentral

Jickling, G. C., Ander, B. P., Zhan, X., Noblett, D., Stamova, B., & Liu, D. (2014a). microRNA expression in peripheral blood cells following acute ischemic stroke and their predicted gene targets. PLoS ONE, 9(6), e99283. https://doi.org/10.1371/journal.pone.0099283.CrossRefPubMedPubMedCentral

Jickling, G. C., Liu, D., Stamova, B., Ander, B. P., Zhan, X., Lu, A., et al. (2014b). Hemorrhagic transformation after ischemic stroke in animals and humans. Journal of Cerebral Blood Flow & Metabolism, 34(2), 185–199. https://doi.org/10.1038/jcbfm.2013.203.CrossRef

Jickling, G. C., & Sharp, F. R. (2011). Blood biomarkers of ischemic stroke. Neurotherapeutics, 8(3), 349–360. https://doi.org/10.1007/s13311-011-0050-4.CrossRefPubMedPubMedCentral

Jickling, G. C., & Sharp, F. R. (2015). Biomarker panels in ischemic stroke. Stroke, 46(3), 915–920. https://doi.org/10.1161/STROKEAHA.114.005604.CrossRefPubMedPubMedCentral

Jickling, G. C., Stamova, B., Ander, B. P., Zhan, X., Tian, Y., Liu, D., et al. (2011). Profiles of lacunar and nonlacunar stroke. Annals of Neurology, 70(3), 477–485. https://doi.org/10.1002/ana.22497.CrossRefPubMedPubMedCentral

Jickling, G. C., Xu, H., Stamova, B., Ander, B. P., Zhan, X., Tian, Y., et al. (2010). Signatures of cardioembolic and large-vessel ischemic stroke. Annals of Neurology, 68(5), 681–692. https://doi.org/10.1002/ana.22187.CrossRefPubMedPubMedCentral

Jickling, G. C., Zhan, X., Stamova, B., Ander, B. P., Tian, Y., Liu, D., et al. (2012). Ischemic transient neurological events identified by immune response to cerebral ischemia. Stroke, 43(4), 1006–1012. https://doi.org/10.1161/STROKEAHA.111.638577.CrossRefPubMedPubMedCentral

Jove, M., Mauri-Capdevila, G., Suarez, I., Cambray, S., Sanahuja, J., Quilez, A., et al. (2015). Metabolomics predicts stroke recurrence after transient ischemic attack. Neurology, 84(1), 36–45. https://doi.org/10.1212/WNL.0000000000001093.CrossRefPubMedPubMedCentral

Kamel, H., Longstreth, W. T. Jr., Tirschwell, D. L., Kronmal, R. A., Broderick, J. P., Palesch, Y. Y., et al. (2018). The AtRial cardiopathy and antithrombotic drugs in prevention after cryptogenic stroke randomized trial: Rationale and methods. International Journal of Stroke. https://doi.org/10.1177/1747493018799981.CrossRefPubMedPubMedCentral

Katan, M., & Elkind, M. S. V. (2018). The potential role of blood biomarkers in patients with ischemic stroke: An expert opinion. Clinical and Translational Neuroscience, 2(1), 1–7. https://doi.org/10.1177/2514183X18768050.CrossRef

Katan, M., Fluri, F., Morgenthaler, N. G., Schuetz, P., Zweifel, C., Bingisser, R., et al. (2009). Copeptin: A novel, independent prognostic marker in patients with ischemic stroke. Annals of Neurology, 66(6), 799–808. https://doi.org/10.1002/ana.21783.CrossRefPubMed

Katan, M., Fluri, F., Schuetz, P., Morgenthaler, N. G., Zweifel, C., Bingisser, R., et al. (2010). Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke. Journal of the American College of Cardiology, 56(13), 1045–1053. https://doi.org/10.1016/j.jacc.2010.02.071.CrossRefPubMed

Katan, M., Moon, Y. P., Paik, M. C., Mueller, B., Huber, A., Sacco, R. L., et al. (2016). Procalcitonin and midregional proatrial natriuretic peptide as markers of ischemic stroke: The Northern Manhattan Study. Stroke, 47(7), 1714–1719. https://doi.org/10.1161/STROKEAHA.115.011392.CrossRefPubMedPubMedCentral

Katan, M., Moon, Y. P., Paik, M. C., Wolfert, R. L., Sacco, R. L., & Elkind, M. S. (2014). Lipoprotein-associated phospholipase A2 is associated with atherosclerotic stroke risk: The Northern Manhattan Study. PLoS ONE, 9(1), e83393. https://doi.org/10.1371/journal.pone.0083393.CrossRefPubMedPubMedCentral

Katan, M., Nigro, N., Fluri, F., Schuetz, P., Morgenthaler, N. G., Jax, F., et al. (2011). Stress hormones predict cerebrovascular re-events after transient ischemic attacks. Neurology, 76(6), 563–566. https://doi.org/10.1212/WNL.0b013e31820b75e6.CrossRefPubMed

Katsanos, A. H., Makris, K., Stefani, D., Koniari, K., Gialouri, E., Lelekis, M., et al. (2017). Plasma glial fibrillary acidic protein in the differential diagnosis of intracerebral hemorrhage. Stroke, 48(9), 2586–2588. https://doi.org/10.1161/STROKEAHA.117.018409.CrossRefPubMed

Kazmierski, R., Michalak, S., Wencel-Warot, A., & Nowinski, W. L. (2012). Serum tight-junction proteins predict hemorrhagic transformation in ischemic stroke patients. Neurology, 79(16), 1677–1685. https://doi.org/10.1212/WNL.0b013e31826e9a83.CrossRefPubMed

Kelly, P. J., Albers, G. W., Chatzikonstantinou, A., De Marchis, G. M., Ferrari, J., George, P., et al. (2016). Validation and comparison of imaging-based scores for prediction of early stroke risk after transient ischaemic attack: A pooled analysis of individual-patient data from cohort studies. The Lancet Neurology, 15(12), 1238–1247. https://doi.org/10.1016/S1474-4422(16)30236-8.CrossRefPubMed

Kernagis, D. N., & Laskowitz, D. T. (2012). Evolving role of biomarkers in acute cerebrovascular disease. Annals of Neurology, 71(3), 289–303. https://doi.org/10.1002/ana.22553.CrossRefPubMed

Kernan, W. N., Viscoli, C. M., Brass, L. M., Makuch, R. W., Sarrel, P. M., Roberts, R. S., et al. (2000). The stroke prognosis instrument II (SPI-II): A clinical prediction instrument for patients with transient ischemia and nondisabling ischemic stroke. Stroke, 31(2), 456–462.CrossRefPubMed

Keyt, B. A., Paoni, N. F., Refino, C. J., Berleau, L., Nguyen, H., Chow, A., et al. (1994). A faster-acting and more potent form of tissue plasminogen activator. Proceedings of the National Academy of Sciences of the United States of America, 91(9), 3670–3674.CrossRefPubMedPubMedCentral

Khan, S. Q., Dhillon, O., Kelly, D., Squire, I. B., Struck, J., Quinn, P., et al. (2008). Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: Comparison with plasma midregional pro-atrial natriuretic peptide: The LAMP (Leicester Acute Myocardial Infarction Peptide) study. Journal of the American College of Cardiology, 51(19), 1857–1864. https://doi.org/10.1016/j.jacc.2008.01.041.CrossRefPubMed

Knoflach, M., Lang, W., Seyfang, L., Fertl, E., Oberndorfer, S., Daniel, G., et al. (2016). Predictive value of ABCD2 and ABCD3-I scores in TIA and minor stroke in the stroke unit setting. Neurology, 87(9), 861–869. https://doi.org/10.1212/WNL.0000000000003033.CrossRefPubMed

Kumar, S., Selim, M. H., & Caplan, L. R. (2010). Medical complications after stroke. The Lancet Neurology, 9(1), 105–118. https://doi.org/10.1016/S1474-4422(09)70266-2.CrossRefPubMed

Lalive, P. H. (2011). Biomarkers in neuroimmunology. Revue Médicale Suisse, 7(291), 860–866.PubMed

Li, J., & Wang, Y. (2016). Blood biomarkers in minor stroke and transient ischemic attack. Neuroscience Bulletin, 32(5), 463–468. https://doi.org/10.1007/s12264-016-0038-5.CrossRefPubMedPubMedCentral

Li, J., Wang, Y., Wang, D., Lin, J., Wang, A., Zhao, X., et al. (2015). Glycated albumin predicts the effect of dual and single antiplatelet therapy on recurrent stroke. Neurology, 84(13), 1330–1336. https://doi.org/10.1212/WNL.0000000000001421.CrossRefPubMed

Li, J., Zhao, X., Meng, X., Lin, J., Liu, L., Wang, C., et al. (2016). High-sensitive C-reactive protein predicts recurrent stroke and poor functional outcome: Subanalysis of the clopidogrel in high-risk patients with acute nondisabling cerebrovascular events trial. Stroke, 47(8), 2025–2030. https://doi.org/10.1161/STROKEAHA.116.012901.CrossRefPubMed

Llombart, V., Antolin-Fontes, A., Bustamante, A., Giralt, D., Rost, N. S., Furie, K., et al. (2015). B-type natriuretic peptides help in cardioembolic stroke diagnosis: Pooled data meta-analysis. Stroke, 46(5), 1187–1195. https://doi.org/10.1161/STROKEAHA.114.008311.CrossRefPubMed

Llombart, V., Garcia-Berrocoso, T., Bustamante, A., Giralt, D., Rodriguez-Luna, D., Muchada, M., et al. (2016). Plasmatic retinol-binding protein 4 and glial fibrillary acidic protein as biomarkers to differentiate ischemic stroke and intracerebral hemorrhage. Journal of Neurochemistry, 136(2), 416–424. https://doi.org/10.1111/jnc.13419.CrossRefPubMed

Longstreth, W. T. Jr., Kronmal, R. A., Thompson, J. L., Christenson, R. H., Levine, S. R., Gross, R., et al. (2013). Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy. Stroke, 44(3), 714–719. https://doi.org/10.1161/STROKEAHA.112.675942.CrossRefPubMedPubMedCentral

Lorenz, M. W., Markus, H. S., Bots, M. L., Rosvall, M., & Sitzer, M. (2007). Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis. Circulation, 115(4), 459–467. https://doi.org/10.1161/CIRCULATIONAHA.106.628875.CrossRefPubMed

Luger, S., Witsch, J., Dietz, A., Hamann, G. F., Minnerup, J., Schneider, H., et al. (2017). Glial fibrillary acidic protein serum levels distinguish between intracerebral hemorrhage and cerebral ischemia in the early phase of stroke. Clinical Chemistry, 63(1), 377–385. https://doi.org/10.1373/clinchem.2016.263335.CrossRefPubMed

Lynch, J. R., Blessing, R., White, W. D., Grocott, H. P., Newman, M. F., & Laskowitz, D. T. (2004). Novel diagnostic test for acute stroke. Stroke, 35(1), 57–63. https://doi.org/10.1161/01.STR.0000105927.62344.4C.CrossRefPubMed

Magenta, A., Sileno, S., D’Agostino, M., Persiani, F., Beji, S., Paolini, A., et al. (2018). Atherosclerotic plaque instability in carotid arteries: miR-200c as a promising biomarker. Clinical Science(London), 132(22), 2423–2436. https://doi.org/10.1042/CS20180684.CrossRef

Maitrias, P., Metzinger-Le Meuth, V., Nader, J., Reix, T., Caus, T., & Metzinger, L. (2017). The involvement of miRNA in carotid-related stroke. Arteriosclerosis, Thrombosis, and Vascular Biology, 37(9), 1608–1617. https://doi.org/10.1161/ATVBAHA.117.309233.CrossRefPubMed

Makris, K., Haliassos, A., Chondrogianni, M., & Tsivgoulis, G. (2018). Blood biomarkers in ischemic stroke: Potential role and challenges in clinical practice and research. Critical Reviews in Clinical Laboratory Sciences, 55(5), 294–328. https://doi.org/10.1080/10408363.2018.1461190.CrossRefPubMed

Markus, H. S., Larsson, S. C., Kuker, W., Schulz, U. G., Ford, I., Rothwell, P. M., et al. (2017). Stenting for symptomatic vertebral artery stenosis: The vertebral artery ischaemia stenting trial. Neurology, 89(12), 1229–1236. https://doi.org/10.1212/WNL.0000000000004385.CrossRefPubMedPubMedCentral

Marti-Fabregas, J., Borrell, M., Cocho, D., Belvis, R., Castellanos, M., Montaner, J., et al. (2005). Hemostatic markers of recanalization in patients with ischemic stroke treated with rt-PA. Neurology, 65(3), 366–370. https://doi.org/10.1212/01.wnl.0000171704.50395.ba.CrossRefPubMed

Missler, U., Wiesmann, M., Friedrich, C., & Kaps, M. (1997). S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke, 28(10), 1956–1960.CrossRefPubMed

Missler, U., Wiesmann, M., Wittmann, G., Magerkurth, O., & Hagenstrom, H. (1999). Measurement of glial fibrillary acidic protein in human blood: Analytical method and preliminary clinical results. Clinical Chemistry, 45(1), 138–141.PubMed

Mocco, J., Choudhri, T. F., Mack, W. J., Laufer, I., Lee, J., Kiss, S., et al. (2001). Elevation of soluble intercellular adhesion molecule-1 levels in symptomatic and asymptomatic carotid atherosclerosis. Neurosurgery, 48(4), 718–721. (discussion 721–712).PubMed

Modak, J. M., Roy-O’Reilly, M., Zhu, L., Staff, I., & McCullough, L. D. (2018). Differential microribonucleic acid expression in cardioembolic stroke. Journal of Stroke and Cerebrovascular Diseases. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.09.018.CrossRefPubMedPubMedCentral

Montaner, J., Perea-Gainza, M., Delgado, P., Ribo, M., Chacon, P., Rosell, A., et al. (2008). Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke, 39(8), 2280–2287. https://doi.org/10.1161/STROKEAHA.107.505354.CrossRefPubMed

Nash, D. L., Bellolio, M. F., & Stead, L. G. (2008). S100 as a marker of acute brain ischemia: A systematic review. Neurocritical Care, 8(2), 301–307. https://doi.org/10.1007/s12028-007-9019-x.CrossRefPubMed

Ng, G. J. L., Quek, A. M. L., Cheung, C., Arumugam, T. V., & Seet, R. C. S (2017). Stroke biomarkers in clinical practice: A critical appraisal. Neurochemistry International, 107, 11–22. https://doi.org/10.1016/j.neuint.2017.01.005.CrossRefPubMed

Nogueira, R. G., Jadhav, A. P., Haussen, D. C., Bonafe, A., Budzik, R. F., Bhuva, P., et al. (2018). Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. The New England Journal of Medicine, 378(1), 11–21. https://doi.org/10.1056/NEJMoa1706442.CrossRefPubMed

Olivot, J. M., Labreuche, J., Aiach, M., Amarenco, P., & Investigators, G. (2004). Soluble thrombomodulin and brain infarction: Case-control and prospective study. Stroke, 35(8), 1946–1951. https://doi.org/10.1161/01.STR.0000133340.37712.9b.CrossRefPubMed

Paraskevas, K. I., Veith, F. J., & Spence, J. D. (2018). How to identify which patients with asymptomatic carotid stenosis could benefit from endarterectomy or stenting. Stroke and Vascular Neurology, 3(2), 92–100. https://doi.org/10.1136/svn-2017-000129.CrossRefPubMedPubMedCentral

Park, S. Y., Kim, J., Kim, O. J., Kim, J. K., Song, J., Shin, D. A., et al. (2013a). Predictive value of circulating interleukin-6 and heart-type fatty acid binding protein for three months clinical outcome in acute cerebral infarction: Multiple blood markers profiling study. Critical Care, 17(2), R45. https://doi.org/10.1186/cc12564.CrossRefPubMedPubMedCentral

Park, S. Y., Kim, M. H., Kim, O. J., Ahn, H. J., Song, J. Y., Jeong, J. Y., et al. (2013b). Plasma heart-type fatty acid binding protein level in acute ischemic stroke: Comparative analysis with plasma S100B level for diagnosis of stroke and prediction of long-term clinical outcome. Clinical Neurology and Neurosurgery, 115(4), 405–410. https://doi.org/10.1016/j.clineuro.2012.06.004.CrossRefPubMed

Park, K. Y., Ay, I., Avery, R., Caceres, J. A., Siket, M. S., Pontes-Neto, O. M., et al. (2018). New biomarker for acute ischaemic stroke: Plasma glycogen phosphorylase isoenzyme BB. Journal of Neurology, Neurosurgery, and Psychiatry, 89(4), 404–409. https://doi.org/10.1136/jnnp-2017-316084.CrossRefPubMed

Penn, A. M., Bibok, M. B., Saly, V. K., Coutts, S. B., Lesperance, M. L., Balshaw, R. F., et al. (2018). Verification of a proteomic biomarker panel to diagnose minor stroke and transient ischaemic attack: Phase 1 of SpecTRA, a large scale translational study. Biomarkers, 23(4), 392–405. https://doi.org/10.1080/1354750X.2018.1434681.CrossRefPubMed

Perry, L. A., Lucarelli, T., Penny-Dimri, J. C., McInnes, M. D., Mondello, S., Bustamante, A., et al. (2018). Glial fibrillary acidic protein for the early diagnosis of intracerebral hemorrhage: Systematic review and meta-analysis of diagnostic test accuracy. International Journal of Stroke. https://doi.org/10.1177/1747493018806167.CrossRefPubMed

Poli, S., Hartig, F., Selim, M. H., Molina, C. A., & Dowlatshahi, D. (2017). Prothrombin complex concentrates use in intracerebral hemorrhage. Stroke, 48(9), 2644–2646. https://doi.org/10.1161/STROKEAHA.117.017591.CrossRefPubMed

Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., et al. (2018). 2018 guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 49(3), e46–e110. https://doi.org/10.1161/STR.0000000000000158.CrossRefPubMed

Ramos-Fernandez, M., Bellolio, M. F., & Stead, L. G. (2011). Matrix metalloproteinase-9 as a marker for acute ischemic stroke: A systematic review. Journal of Stroke and Cerebrovascular Diseases, 20(1), 47–54. https://doi.org/10.1016/j.jstrokecerebrovasdis.2009.10.008.CrossRefPubMed

Ren, C., Kobeissy, F., Alawieh, A., Li, N., Li, N., Zibara, K., et al. (2016). Assessment of Serum UCH-L1 and GFAP in acute stroke patients. Scientific Reports, 6, 24588. https://doi.org/10.1038/srep24588.CrossRefPubMedPubMedCentral

Ribo, M., Montaner, J., Molina, C. A., Arenillas, J. F., Santamarina, E., & Alvarez-Sabin, J. (2004a). Admission fibrinolytic profile predicts clot lysis resistance in stroke patients treated with tissue plasminogen activator. Thrombosis and Haemostasis, 91(6), 1146–1151. https://doi.org/10.1160/TH04-02-0097.CrossRefPubMed

Ribo, M., Montaner, J., Molina, C. A., Arenillas, J. F., Santamarina, E., Quintana, M., et al. (2004b). Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator. Stroke, 35(9), 2123–2127. https://doi.org/10.1161/01.STR.0000137608.73660.4c.CrossRefPubMed

Ridker, P. M., MacFadyen, J. G., Wolfert, R. L., & Koenig, W. (2012). Relationship of lipoprotein-associated phospholipase A(2) mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: An analysis from the JUPITER trial. Clinical Chemistry, 58(5), 877–886. https://doi.org/10.1373/clinchem.2011.180281.CrossRefPubMed

Riedel, C. H., Zimmermann, P., Jensen-Kondering, U., Stingele, R., Deuschl, G., & Jansen, O. (2011). The importance of size: Successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke, 42(6), 1775–1777. https://doi.org/10.1161/STROKEAHA.110.609693.CrossRefPubMed

Rodriguez-Yanez, M., Sobrino, T., Arias, S., Vazquez-Herrero, F., Brea, D., Blanco, M., et al. (2011). Early biomarkers of clinical-diffusion mismatch in acute ischemic stroke. Stroke, 42(10), 2813–2818. https://doi.org/10.1161/STROKEAHA.111.614503.CrossRefPubMed

Rosell, A., Cuadrado, E., Alvarez-Sabin, J., Hernandez-Guillamon, M., Delgado, P., Penalba, A., et al. (2008). Caspase-3 is related to infarct growth after human ischemic stroke. Neuroscience Letters, 430(1), 1–6. https://doi.org/10.1016/j.neulet.2007.05.006.CrossRefPubMed

Rothwell, P. M. (2018). Clinical innovation in stroke: Getting the simple things right. The Lancet Neurology, 17(6), 491–493. https://doi.org/10.1016/S1474-4422(18)30113-3.CrossRefPubMed

Rozanski, M., & Audebert, H. J. (2018). Glial fibrillary acidic protein in acute stroke: What we know and what we need to know. AME Medical Journal. https://doi.org/10.21037/amj.2018.01.04 CrossRef

Rozanski, M., Waldschmidt, C., Kunz, A., Grittner, U., Ebinger, M., Wendt, M., et al. (2017). Glial fibrillary acidic protein for prehospital diagnosis of intracerebral hemorrhage. Cerebrovascular Diseases, 43(1–2), 76–81. https://doi.org/10.1159/000453460.CrossRefPubMed

Sato, M., Suzuki, A., Nagata, K., & Uchiyama, S. (2006). Increased von Willebrand factor in acute stroke patients with atrial fibrillation. Journal of Stroke and Cerebrovascular Diseases, 15(1), 1–7. https://doi.org/10.1016/j.jstrokecerebrovasdis.2005.09.005.CrossRefPubMed

Saver, J. L. (2016). Cryptogenic stroke. The New England Journal of Medicine, 375(11), e26. https://doi.org/10.1056/NEJMc1609156.CrossRefPubMed

Seiffge, D. J., Werring, D. J., Paciaroni, M., Dawson, J., Warach, S., Milling, T. J., et al. (2018). Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation. The Lancet Neurology. https://doi.org/10.1016/S1474-4422(18)30356-9.CrossRefPubMedPubMedCentral

Serena, J., Blanco, M., Castellanos, M., Silva, Y., Vivancos, J., Moro, M. A., et al. (2005). The prediction of malignant cerebral infarction by molecular brain barrier disruption markers. Stroke, 36(9), 1921–1926. https://doi.org/10.1161/01.STR.0000177870.14967.94.CrossRefPubMed

Sharp, F. R., & Jickling, G. C. (2013). Whole genome expression of cellular response to stroke. Stroke, 44(6 Suppl 1), S23–S25. https://doi.org/10.1161/STROKEAHA.112.679357.CrossRefPubMedPubMedCentral

Sharp, F. R., Jickling, G. C., Stamova, B., Tian, Y., Zhan, X., Liu, D., et al. (2011). Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humans. Journal of Cerebral Blood Flow & Metabolism, 31(7), 1513–1531. https://doi.org/10.1038/jcbfm.2011.45.CrossRef

Sharp, F. R., Lu, A., Tang, Y., & Millhorn, D. E. (2000). Multiple molecular penumbras after focal cerebral ischemia. Journal of Cerebral Blood Flow & Metabolism, 20(7), 1011–1032. https://doi.org/10.1097/00004647-200007000-00001.CrossRef

Si, W., He, P., Wang, Y., Fu, Y., Li, X., Lin, X., et al. (2018). Complement complex C5b-9 levels are associated with the clinical outcomes of acute ischemic stroke and carotid plaque stability. Translational Stroke Research. https://doi.org/10.1007/s12975-018-0658-3.CrossRefPubMedPubMedCentral

Simats, A., Garcia-Berrocoso, T., & Montaner, J. (2016). Neuroinflammatory biomarkers: From stroke diagnosis and prognosis to therapy. Biochimica et Biophysica Acta, 1862(3), 411–424. https://doi.org/10.1016/j.bbadis.2015.10.025.CrossRefPubMed

Sonneveld, M. A., de Maat, M. P., Portegies, M. L., Kavousi, M., Hofman, A., Turecek, P. L., et al. (2015). Low ADAMTS13 activity is associated with an increased risk of ischemic stroke. Blood, 126(25), 2739–2746. https://doi.org/10.1182/blood-2015-05-643338.CrossRefPubMed

Sonneveld, M. A., Franco, O. H., Ikram, M. A., Hofman, A., Kavousi, M., de Maat, M. P., et al. (2016). Von Willebrand Factor, ADAMTS13, and the risk of mortality: The Rotterdam study. Arteriosclerosis, Thrombosis, and Vascular Biology, 36(12), 2446–2451. https://doi.org/10.1161/ATVBAHA.116.308225.CrossRefPubMed

Stability Investigators, White, H. D., Held, C., Stewart, R., Tarka, E., Brown, R., et al. (2014). Darapladib for preventing ischemic events in stable coronary heart disease. The New England Journal of Medicine, 370(18), 1702–1711. https://doi.org/10.1056/NEJMoa1315878.CrossRef

Stamova, B., Ander, B. P., Jickling, G., Hamade, F., Durocher, M., Zhan, X., et al. (2018). The intracerebral hemorrhage blood transcriptome in humans differs from the ischemic stroke and vascular risk factor control blood transcriptomes. Journal of Cerebral Blood Flow & Metabolism. https://doi.org/10.1177/0271678X18769513.CrossRef

Stamova, B., Xu, H., Jickling, G., Bushnell, C., Tian, Y., Ander, B. P., et al. (2010). Gene expression profiling of blood for the prediction of ischemic stroke. Stroke, 41(10), 2171–2177. https://doi.org/10.1161/STROKEAHA.110.588335.CrossRefPubMedPubMedCentral

Stanca, D. M., Marginean, I. C., Soritau, O., Dragos, C., Marginean, M., Muresanu, D. F., et al. (2015). GFAP and antibodies against NMDA receptor subunit NR2 as biomarkers for acute cerebrovascular diseases. Journal of Cellular and Molecular Medicine, 19(9), 2253–2261. https://doi.org/10.1111/jcmm.12614.CrossRefPubMedPubMedCentral

Steadman, C. D., Ray, S., Ng, L. L., & McCann, G. P. (2010). Natriuretic peptides in common valvular heart disease. Journal of the American College of Cardiology, 55(19), 2034–2048. https://doi.org/10.1016/j.jacc.2010.02.021.CrossRefPubMed

Suwanwela, N. C., Chutinet, A., & Phanthumchinda, K. (2006). Inflammatory markers and conventional atherosclerotic risk factors in acute ischemic stroke: Comparative study between vascular disease subtypes. Journal of the Medical Association of Thailand, 89(12), 2021–2027.PubMed

Switzer, J. A., Hess, D. C., Ergul, A., Waller, J. L., Machado, L. S., Portik-Dobos, V., et al. (2011). Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke. Stroke, 42(9), 2633–2635. https://doi.org/10.1161/STROKEAHA.111.618215.CrossRefPubMedPubMedCentral

Tang, Y., Lu, A., Aronow, B. J., & Sharp, F. R. (2001). Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: Blood genomic fingerprints of disease. Annals of Neurology, 50(6), 699–707.CrossRefPubMed

Tang, Y., Xu, H., Du, X., Lit, L., Walker, W., Lu, A., et al. (2006). Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: A microarray study. Journal of Cerebral Blood Flow & Metabolism, 26(8), 1089–1102. https://doi.org/10.1038/sj.jcbfm.9600264.CrossRef

Tanne, D., Macko, R. F., Lin, Y., Tilley, B. C., Levine, S. R., & Group, N. r. S. S. (2006). Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke. Stroke, 37(7), 1798–1804. https://doi.org/10.1161/01.STR.0000226897.43749.27.CrossRefPubMed

Thiebaut, A. M., Gauberti, M., Ali, C., De Lizarrondo, M., Vivien, S., Yepes, D., M., et al (2018). The role of plasminogen activators in stroke treatment: Fibrinolysis and beyond. The Lancet Neurology, 17(12), 1121–1132. https://doi.org/10.1016/S1474-4422(18)30323-5.CrossRefPubMed

Thomalla, G., Simonsen, C. Z., Boutitie, F., Andersen, G., Berthezene, Y., Cheng, B., et al. (2018). MRI-guided thrombolysis for stroke with unknown time of onset. The New England Journal of Medicine, 379(7), 611–622. https://doi.org/10.1056/NEJMoa1804355.CrossRefPubMed

Tiedt, S., Duering, M., Barro, C., Kaya, A. G., Boeck, J., Bode, F. J., et al. (2018). Serum neurofilament light: A biomarker of neuroaxonal injury after ischemic stroke. Neurology, 91(14), e1338–e1347. https://doi.org/10.1212/WNL.0000000000006282.CrossRefPubMed

Touboul, P. J., Hennerici, M. G., Meairs, S., Adams, H., Amarenco, P., Bornstein, N., et al. (2012). Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovascular Diseases, 34(4), 290–296. https://doi.org/10.1159/000343145.CrossRefPubMed

Tu, L., Liu, X., Li, T., Yang, X., Ren, Y., Zhang, Q., et al. (2018). Admission serum calcium level as a prognostic marker for intracerebral hemorrhage. Neurocritical Care. https://doi.org/10.1007/s12028-018-0574-0.CrossRefPubMed

Tu, W. J., Zhao, S. J., Xu, D. J., & Chen, H. (2014). Serum 25-hydroxyvitamin D predicts the short-term outcomes of Chinese patients with acute ischaemic stroke. Clinical Science (London), 126(5), 339–346. https://doi.org/10.1042/CS20130284.CrossRef

Turaj, W., Slowik, A., Dziedzic, T., Pulyk, R., Adamski, M., Strojny, J., et al. (2006). Increased plasma fibrinogen predicts one-year mortality in patients with acute ischemic stroke. Journal of the Neurological Sciences, 246(1–2), 13–19. https://doi.org/10.1016/j.jns.2006.01.020.CrossRefPubMed

Tuttolomondo, A., Di Sciacca, R., Di Raimondo, D., Serio, A., D’Aguanno, G., La Placa, S., et al. (2009). Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: Relationship with TOAST subtype, outcome and infarct site. Journal of Neuroimmunology, 215(1–2), 84–89. https://doi.org/10.1016/j.jneuroim.2009.06.019.CrossRefPubMed

Twerenbold, R., Boeddinghaus, J., Nestelberger, T., Wildi, K., Rubini Gimenez, M., Badertscher, P., et al. (2017). Clinical use of high-sensitivity cardiac troponin in patients with suspected myocardial infarction. Journal of the American College of Cardiology, 70(8), 996–1012. https://doi.org/10.1016/j.jacc.2017.07.718.CrossRefPubMed

Uno, M., Kitazato, K. T., Nishi, K., Itabe, H., & Nagahiro, S. (2003). Raised plasma oxidised LDL in acute cerebral infarction. Journal of Neurology, Neurosurgery, and Psychiatry, 74(3), 312–316.CrossRefPubMedPubMedCentral

Urbich, C., Kuehbacher, A., & Dimmeler, S. (2008). Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovascular Research, 79(4), 581–588. https://doi.org/10.1093/cvr/cvn156.CrossRefPubMed

Vahedi, K., Hofmeijer, J., Juettler, E., Vicaut, E., George, B., Algra, A., et al. (2007). Early decompressive surgery in malignant infarction of the middle cerebral artery: A pooled analysis of three randomised controlled trials. The Lancet Neurology, 6(3), 215–222. https://doi.org/10.1016/S1474-4422(07)70036-4.CrossRefPubMed

VanGilder, R. L., Davidov, D. M., Stinehart, K. R., Huber, J. D., Turner, R. C., Wilson, K. S., et al. (2014). C-reactive protein and long-term ischemic stroke prognosis. Journal of Clinical Neuroscience, 21(4), 547–553. https://doi.org/10.1016/j.jocn.2013.06.015.CrossRefPubMed

Wang, H., Cheng, Y., Chen, S., Li, X., Zhu, Z., & Zhang, W. (2018). Impact of elevated hemoglobin A1c levels on functional outcome in patients with acute ischemic stroke. Journal of Stroke and Cerebrovascular Diseases. https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.10.026.CrossRefPubMedPubMedCentral

Wang, J., Ruan, J., Zhu, M., Yang, J., Du, S., Xu, P., et al. (2018). Predictive value of long noncoding RNA ZFAS1 in patients with ischemic stroke. Clinical and Experimental Hypertension. https://doi.org/10.1080/10641963.2018.1529774.CrossRefPubMedPubMedCentral

White, H. D., Simes, J., Stewart, R. A., Blankenberg, S., Barnes, E. H., Marschner, I. C., et al. (2013). Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: Results from the Long-Term Intervention with Pravastatin in Ischemic Disease study. Journal of the American Heart Association, 2(5), e000360. https://doi.org/10.1161/JAHA.113.000360.CrossRefPubMedPubMedCentral

Whiteley, W., Chong, W. L., Sengupta, A., & Sandercock, P. (2009a). Blood markers for the prognosis of ischemic stroke: A systematic review. Stroke, 40(5), e380–e389. https://doi.org/10.1161/STROKEAHA.108.528752.CrossRefPubMed

Whiteley, W., Jackson, C., Lewis, S., Lowe, G., Rumley, A., Sandercock, P., et al. (2009b). Inflammatory markers and poor outcome after stroke: A prospective cohort study and systematic review of interleukin-6. PLoS Medicine, 6(9), e1000145. https://doi.org/10.1371/journal.pmed.1000145.CrossRefPubMedPubMedCentral

Whiteley, W., Tian, Y., & Jickling, G. C. (2012a). Blood biomarkers in stroke: Research and clinical practice. International Journal of Stroke, 7(5), 435–439. https://doi.org/10.1111/j.1747-4949.2012.00784.x.CrossRefPubMed

Whiteley, W., Tseng, M. C., & Sandercock, P. (2008). Blood biomarkers in the diagnosis of ischemic stroke: A systematic review. Stroke, 39(10), 2902–2909. https://doi.org/10.1161/STROKEAHA.107.511261.CrossRefPubMed

Whiteley, W., Wardlaw, J., Dennis, M., Lowe, G., Rumley, A., Sattar, N., et al. (2012b). The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke. Stroke, 43(1), 86–91. https://doi.org/10.1161/STROKEAHA.111.634089.CrossRefPubMed

Wiseman, S., Marlborough, F., Doubal, F., Webb, D. J., & Wardlaw, J. (2014). Blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-lacunar stroke and non-stroke: Systematic review and meta-analysis. Cerebrovascular Diseases, 37(1), 64–75. https://doi.org/10.1159/000356789.CrossRefPubMed

Wunderlich, M. T., Lins, H., Skalej, M., Wallesch, C. W., & Goertler, M. (2006). Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke. Clinical Neurology and Neurosurgery, 108(6), 558–563. https://doi.org/10.1016/j.clineuro.2005.12.006.CrossRefPubMed

Wyseure, T., Rubio, M., Denorme, F., Martinez de Lizarrondo, S., Peeters, M., Gils, A., et al. (2015). Innovative thrombolytic strategy using a heterodimer diabody against TAFI and PAI-1 in mouse models of thrombosis and stroke. Blood, 125(8), 1325–1332. https://doi.org/10.1182/blood-2014-07-588319.CrossRefPubMed

Xie, S., Lu, L., Liu, L., Bi, G., & Zheng, L. (2016). Progranulin and short-term outcome in patients with acute ischaemic stroke. European Journal of Neurology, 23(3), 648–655. https://doi.org/10.1111/ene.12920.CrossRefPubMed

Xiong, L., Yang, Y., Zhang, M., & Xu, W. (2015). The use of serum glial fibrillary acidic protein test as a promising tool for intracerebral hemorrhage diagnosis in Chinese patients and prediction of the short-term functional outcomes. Neurological Sciences, 36(11), 2081–2087. https://doi.org/10.1007/s10072-015-2317-8.CrossRefPubMed

Xu, Q., Tian, Y., Peng, H., & Li, H. (2017). Copeptin as a biomarker for prediction of prognosis of acute ischemic stroke and transient ischemic attack: A meta-analysis. Hypertension Research, 40(5), 465–471. https://doi.org/10.1038/hr.2016.165.CrossRefPubMed

Xu, T., Zuo, P., Cao, L., Gao, Z., & Ke, K. (2018). Omentin-1 is associated with carotid plaque instability among ischemic stroke patients. Journal of Atherosclerosis and Thrombosis, 25(6), 505–511. https://doi.org/10.5551/jat.42135.CrossRefPubMedPubMedCentral

Yaghi, S., Bernstein, R. A., Passman, R., Okin, P. M., & Furie, K. L. (2017a). Cryptogenic stroke: Research and practice. Circulation Research, 120(3), 527–540. https://doi.org/10.1161/CIRCRESAHA.116.308447.CrossRefPubMed

Yaghi, S., Willey, J. Z., Cucchiara, B., Goldstein, J. N., Gonzales, N. R., Khatri, P., et al. (2017b). Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: A scientific statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 48(12), e343–e361. https://doi.org/10.1161/STR.0000000000000152.CrossRefPubMed

Yip, H. K., Lu, C. H., Yang, C. H., Chang, H. W., Hung, W. C., Cheng, C. I., et al. (2006). Levels and value of platelet activity in patients with severe internal carotid artery stenosis. Neurology, 66(6), 804–808. https://doi.org/10.1212/01.wnl.0000208220.04165.05.CrossRefPubMed

Yoon, C. W., Kim, S. J., Bang, O. Y., Chung, C. S., Lee, K. H., & Kim, G. M. (2012). Premorbid warfarin use and lower D-dimer levels are associated with a spontaneous early improvement in an atrial fibrillation-related stroke. Journal of Thrombosis and Haemostasis, 10(11), 2394–2396. https://doi.org/10.1111/j.1538-7836.2012.04909.x.CrossRefPubMed

Zhan, X., Jickling, G. C., Tian, Y., Stamova, B., Xu, H., Ander, B. P., et al. (2011). Transient ischemic attacks characterized by RNA profiles in blood. Neurology, 77(19), 1718–1724. https://doi.org/10.1212/WNL.0b013e318236eee6.CrossRefPubMedPubMedCentral

Zhang, Z. G., Wang, C., Wang, J., Zhang, Z., Yang, Y. L., Gao, L., et al. (2015). Prognostic value of mannose-binding lectin: 90-day outcome in patients with acute ischemic stroke. Molecular Neurobiology, 51(1), 230–239. https://doi.org/10.1007/s12035-014-8682-0.CrossRefPubMed

Zhao, X., Yu, Y., Xu, W., Dong, L., Wang, Y., Gao, B., et al. (2016). Apolipoprotein A1-unique peptide as a diagnostic biomarker for acute ischemic stroke. International Journal of Molecular Sciences, 17(4), 458. https://doi.org/10.3390/ijms17040458.CrossRefPubMedPubMedCentral

Zhou, S., Bao, J., Wang, Y., & Pan, S. (2016). S100beta as a biomarker for differential diagnosis of intracerebral hemorrhage and ischemic stroke. Neurological Research, 38(4), 327–332. https://doi.org/10.1080/01616412.2016.1152675.CrossRefPubMed

Zhu, Y. Y., Zhang, J. L., Liu, L., Han, Y., Ge, X., & Zhao, S. (2018). Evaluation of serum retinol-binding protein-4 levels as a biomarker of poor short-term prognosis in ischemic stroke. Bioscience Reports. https://doi.org/10.1042/BSR20180786.CrossRefPubMedPubMedCentral

Zhu, Z., Tang, W., Ge, L., Han, X., & Dong, Q. (2018). The value of plasma fibrillin-1 level in patients with spontaneous cerebral artery dissection. Neurology, 90(9), e732–e737. https://doi.org/10.1212/WNL.0000000000005027.CrossRefPubMed

Zimmermann-Ivol, C. G., Burkhard, P. R., Floch-Rohr, L., Allard, L., Hochstrasser, D. F., & Sanchez, J. C. (2004). Fatty acid binding protein as a serum marker for the early diagnosis of stroke: A pilot study. Molecular & Cellular Proteomics, 3(1), 66–72. https://doi.org/10.1074/mcp.M300066-MCP200.CrossRef

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Blood Biomarkers for Stroke Diagnosis and Management

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

Manche Gestagene können das Risiko für Meningeome erhöhen

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

Update Neurologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2019

Stroke: Molecular Mechanisms and Therapies

Acetyl-11-keto-β-boswellic acid (AKBA) Attenuates Oxidative Stress, Inflammation, Complement Activation and Cell Death in Brain Endothelial Cells Following OGD/Reperfusion

Blockade of Acid-Sensing Ion Channels Attenuates Recurrent Hypoglycemia-Induced Potentiation of Ischemic Brain Damage in Treated Diabetic Rats

Acid–Base and Electrolyte Changes Drive Early Pathology in Ischemic Stroke

Preserving Mitochondrial Structure and Motility Promotes Recovery of White Matter After Ischemia